7 February 2020 in IEEE Access
K-means clustering algorithm is one of the most popular technique for clustering in machine learning, however, in the existing k-means clustering algorithm, the ability of the different features and the importance of the different data objects are treated equally; the discriminative ability of the different features and the importance of the different data objects cannot be differentiated effectively. In the light of this limitation, this paper put forward an enhanced regularized k-means type clustering algorithm with adaptive weights in which we introduced an adaptive feature weights matrix and an adaptive data weights vector into the objective function of the k-means clustering algorithm and we developed a new objective function with l2-norm regularization to the weights of data objects and features, then we obtained the corresponding scientific updating iterative rules of the weights of the different features, the weights of the different data objects and the cluster centers theoretically. In order to evaluate the performance of the new algorithm put forward, extensive experiments were conducted. Experimental results have indicated that our proposed algorithm can improve the clustering performance significantly and are more effective with respects to three metrics: the successful clustering rate (SCR), normal mutual information (NMI) and RandIndex.
31 August 2022 in Journal of Oncology
Background. ESCA is one of the digestive tract tumors with a high fatality. It is implicated in an intricate gene regulation process, but the pathogenesis remains ambiguous. Methods. The study used the packages of Limma from R software to analyze DEGs of ESCA in the GEO database and TCGA database. We employed the DAVID website for enrichment analysis, and the string database constructed the PPI network. Hub genes were identified from ESCA DEGs with Cytoscape MCODE. We evaluated the clinical relevance of LOX expression and its DNA methylation in the cBioPortal database and explored the roles of LOX in ESCA immunity, especially immune cell infiltration levels and immune checkpoint expression, by immunedeconv package of R software. Conclusions. The overexpression of LOX in ESCA is regulated by DNA hypomethylation; LOX overexpression or LOX hypomethylation can predict a worse prognosis in patients with ESCA. Besides, LOX may be involved in TIME regulation, promoting the infiltration levels and function of TAM. Hence, high LOX expression affected by DNA hypomethylation has an essential role in patients with ESCA, which may become an effective prognostic marker and therapeutic target.